Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Viridian Therapeutics, Inc.\DE (VRDN) over the last 10 years, with Q3 2025 value amounting to $1.5 million.

  • Viridian Therapeutics, Inc.\DE's Change in Account Payables fell 4723.55% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year increase of 7219.37%. This contributed to the annual value of -$73000.0 for FY2024, which is 9939.37% up from last year.
  • Latest data reveals that Viridian Therapeutics, Inc.\DE reported Change in Account Payables of $1.5 million as of Q3 2025, which was down 4723.55% from $4.6 million recorded in Q2 2025.
  • In the past 5 years, Viridian Therapeutics, Inc.\DE's Change in Account Payables ranged from a high of $8.0 million in Q3 2022 and a low of -$6.6 million during Q1 2023
  • Over the past 5 years, Viridian Therapeutics, Inc.\DE's median Change in Account Payables value was $482000.0 (recorded in 2024), while the average stood at $474105.3.
  • As far as peak fluctuations go, Viridian Therapeutics, Inc.\DE's Change in Account Payables tumbled by 2154193.55% in 2023, and later surged by 281296.3% in 2024.
  • Over the past 5 years, Viridian Therapeutics, Inc.\DE's Change in Account Payables (Quarter) stood at -$1.4 million in 2021, then skyrocketed by 224.11% to $1.7 million in 2022, then tumbled by 186.88% to -$1.5 million in 2023, then plummeted by 158.77% to -$3.9 million in 2024, then surged by 139.41% to $1.5 million in 2025.
  • Its Change in Account Payables was $1.5 million in Q3 2025, compared to $4.6 million in Q2 2025 and $1.8 million in Q1 2025.